CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 43 enrolled
Drug / intervention
Exercise plus Regadenoson (Lexercise) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01109992
NCT01109992Phase 4Completed
CompareCT.gov

Integrated Dual Exercise and Lexiscan PET: IDEAL PET

Brigham and Women's Hospital·interventional·Posted Apr 23, 2010·Updated Oct 25, 2018

In Brief

A Phase 4 clinical trial evaluating Exercise plus Regadenoson (Lexercise) and Regadenoson (Lexiscan) for Coronary Artery Disease. Completed, enrolled 43 participants across 1 site.

Detailed Summary

This is a single-center study of subjects undergoing clinically indicated heart scans for evaluation of known or suspected heart disease. We will also include 10 healthy subjects without known heart disease. We would like to study stress testing of the heart using exercise and a medication called regadenoson. Imaging of the heart will be performed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 23, 2010
Enrollment StartFeb 1, 2011
Primary CompletionJun 6, 2017
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 16.2 years ago

Interventions

Exercise plus Regadenoson (Lexercise)drug

Standard Bruce exercise stress test with regadenoson injection at maximal stress with Rubidium-82 Positron Emission Tomography

Regadenoson (Lexiscan)drug

Regadenoson Rubidium-82 Positron Emission Tomography